Accès libre

Circumventing vascular barriers for effective immunotherapy in brain tumors – focus on glioblastoma

Janusz Rak

Janusz Rak

McGill University, The Research Institute of the McGill University Health CentreMontreal, Canada
Profil Orcid
Recherchez cet auteur sur
Sciendo|Google Scholar
Rak, Janusz
  
06 août 2025
Circumventing vascular barriers for effective immunotherapy in brain tumors – focus on glioblastoma's Cover Image
À propos de cet article
Article précédent
Article suivant
Citez
Télécharger la couverture
Catégorie d'article: Commentary
Publié en ligne: 06 août 2025
Pages: 95 - 105
Reçu: 15 avr. 2025
Accepté: 20 mai 2025
DOI: https://doi.org/10.2478/ahem-2025-0012
Mots clés
© 2025 Janusz Rak, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Figure 1.

Targeting the immune-vascular interface in glioblastoma. The combined effect of blood-brain barrier (BBB), blood-tumor barrier (BTB), and endothelial anergy contributes to the exclusion of immune cells (T, NK) from the brain tumor microenvironment. Overcoming this scarcity by intracranial delivery of immune cells, modulating vascular wall (para-endothelial gaps), coupled with tumor debulking (to reduce the size of the target cell population) and targeting immunosuppressive mechanisms may collectively improve outcomes of immunotherapy in glioblastoma and other brain tumors (see text)
Targeting the immune-vascular interface in glioblastoma. The combined effect of blood-brain barrier (BBB), blood-tumor barrier (BTB), and endothelial anergy contributes to the exclusion of immune cells (T, NK) from the brain tumor microenvironment. Overcoming this scarcity by intracranial delivery of immune cells, modulating vascular wall (para-endothelial gaps), coupled with tumor debulking (to reduce the size of the target cell population) and targeting immunosuppressive mechanisms may collectively improve outcomes of immunotherapy in glioblastoma and other brain tumors (see text)
Langue:
Anglais
Périodicité:
1 fois par an
Sujets de la revue:
Sciences de la vie, Biologie moléculaire, Microbiologie et virologie, Médecine, Sciences médicales de base, Immunologie
RSS Feed de la revue